share_log

EF Hutton Initiates Coverage On Ocean Biomedical With Buy Rating, Announces Price Target of $10

Benzinga ·  Mar 13, 2023 07:13

EF Hutton analyst Michael King initiates coverage on Ocean Biomedical (NASDAQ:OCEA) with a Buy rating and announces Price Target of $10.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment